Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
about
The synucleinsSecondary structure and dynamics of micelle bound beta- and gamma-synucleinResidual structure, backbone dynamics, and interactions within the synuclein familyDeletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred miceNovel subcellular localization for α-synuclein: possible functional consequencesSynucleins antagonize endoplasmic reticulum function to modulate dopamine transporter traffickingThe Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human DiseaseThe Synaptic Function of α-SynucleinThe contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseRole of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related SynucleinopathiesParkinson's disease as a result of agingReducing synuclein accumulation improves neuronal survival after spinal cord injuryAge-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic miceNeuromythology of ManganismDegradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neuronsFunctionality and Robustness of Injured Connectomic Dynamics in C. elegans: Linking Behavioral Deficits to Neural Circuit DamageHDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damageSynucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerveNeurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the geneHuman alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.Molecular anatomy of the hair cell's ribbon synapseGamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brainAxon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicityProgressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's diseaseAnterior-posterior cerebral blood volume gradient in human subiculum.Quantitative neuropathology associated with chronic manganese exposure in South African mine workersAggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutationsTranscriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1.Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.Neuropathology of synuclein aggregates.Identifying Tmem59 related gene regulatory network of mouse neural stem cell from a compendium of expression profilesClinical progression in Parkinson disease and the neurobiology of axons.Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's diseaseGamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction.Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis.Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.In vivo demonstration that alpha-synuclein oligomers are toxic.
P2860
Q24551013-3762F2E4-54E5-486A-9E41-C4390EBAACC5Q24647859-B2B92B7C-E3AF-4DCA-ABCA-6C17361254AAQ24671058-CD49DC3C-8108-4C66-9D72-DEF5E5F9759BQ24805405-CEDF5E54-ABF3-4140-BDAD-9E128BD0FBC7Q26827605-9A1178EC-3C29-446A-9811-30EBD504631EQ27310037-A3046101-F8D1-4D3A-A724-68E4B83E6F38Q27315090-B5CACBF5-47EA-49B6-A6DD-DC658B8BCBCAQ27694711-AB002088-E121-4DBA-A0E6-43591D296DF3Q28068464-1031477A-CABD-4507-962B-A1FDFEBDED8AQ28083418-2AAC8FD9-42A9-4D36-B59C-E2E592E61A89Q28084395-442F9E70-3316-4A7B-9CAE-00E590B48047Q28273075-F4CF7B6F-448E-4275-BD9D-5039FDEAD1C9Q28346155-A1E25C45-20A1-463C-9608-27D8162CE780Q28395303-0B93F6E6-BD8D-4E8A-A86C-3D2EB452687FQ28511388-F2A8A2AE-1D7A-424F-891B-990684BFA259Q28555219-BA46843F-BBD5-4136-A6EE-65273EF1F0C7Q28569045-37242F34-8D9F-4A95-A872-E99ACC1FA8E9Q28580190-340485E3-8C34-41A4-AD37-14B72D9A814EQ28587583-816877C9-38CC-43A5-8338-0C0AA2ABE258Q30476254-FD9051C8-9175-49EB-9343-8271EBB4E90DQ30476380-5BE2E70E-32FE-4FC5-BAFA-6E0A06178AD3Q30487162-E55CCE23-F896-437D-9395-583E37E7413EQ30498862-59B6728A-CDC3-4B53-89B3-F6EA722A9458Q30577415-24BED794-D65E-4CCC-ACD8-AF245009D178Q30833636-AF97D266-D2D0-4123-A616-3007E05D6EA7Q33688290-894DB9E2-A9CA-4F89-8727-FDFAEC284767Q33812680-8B1A773C-B4CF-4573-90BF-E1DC565C9A9AQ33836384-EEBA3C12-38AD-4A37-B992-1C6243CA025CQ33840954-7B08BE95-A123-4E22-B94A-6ED79DCB78D4Q33843073-4FDAD779-85E5-4857-ADB7-58FE8A5726C2Q33957376-BD8C10CC-F9F1-406C-A6D3-F897A9D35DEBQ34034119-BDB59646-92DF-41FA-B6D6-883075C28057Q34052764-C35BBDCE-8DA2-48B1-A414-8832E856D74CQ34080479-DC105369-CB6F-4EBB-915D-F0CF06DA7D63Q34105358-644B8C00-36AD-4413-B136-BD8622870E65Q34111411-EE415813-BE9E-4F11-9D3E-EEF71E931147Q34207470-53DA1584-93EA-4CC7-931A-548A1F5F0F13Q34323256-E05E1D94-87A9-4342-A73B-57FDDF9A0551Q34518702-092CFCB7-787F-4DD8-BBB6-B83F1B4FE534Q34652122-BF079360-A6EB-428D-91EC-829AD5FDC4B7
P2860
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@ast
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@en
type
label
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@ast
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@en
altLabel
Axon pathology in Parkinson's ...... , beta -, and gamma -synuclein
@en
prefLabel
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@ast
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@en
P2093
P2860
P921
P356
P1476
Axon pathology in Parkinson's ...... -, beta-, and gamma-synuclein.
@en
P2093
P2860
P304
13450-13455
P356
10.1073/PNAS.96.23.13450
P407
P577
1999-11-01T00:00:00Z